Harnessing Dual Phototherapy and Immune Activation for Cancer Treatment: The Development and Application of BODIPY@F127 Nanoparticles
Advanced Healthcare Materials · 2024
DOI: 10.1002/adhm.202401981 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2024. Verfasst von Yang Peng und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Dentistry II, Peking University School and Hospital of Stomatology & National Center for Stomatology & National Clinical Resear…. Hauptthemen laut MEDLINE: Nanoparticles, Boron Compounds. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, National Key Technologies R&D Program, Natural Science Foundation of Henan.
Abstract (Originalsprache)
Conventional phototherapeutic agents are typically used in either photodynamic therapy (PDT) or photothermal therapy (PTT). However, efficacy is often hindered by hypoxia and elevated levels of heat shock proteins in the tumor microenvironment (TME). To address these limitations, a formylated, near‐infrared (NIR)‐absorbing and heavy‐atom‐free Aza‐BODIPY dye is presented that exhibits both type‐I and type‐II PDT actions with a high yield of reactive oxygen species (ROS) and manifests efficient photothermal conversion by precise adjustments to the conjugate structure and electron distribution, leading to a large amount of ROS production even under severe hypoxia. To improve biosafety and water solubility, the dye with an amphiphilic triblock copolymer (Pluronic F‐127), yielding BDP‐6@F127 nanoparticles (NPs) is coated. Furthermore, inspired by the fact that phototherapy triggers the release of tumor‐associated antigens, a strategy that leverages potential immune activation by combining PDT/PTT with immune checkpoint blockade (ICB) therapy to amplify the systemic immune response and achieve the much‐desired abscopal effect is developed. In conclusion, this study presents a promising molecular design strategy that integrates multimodal therapeutics for a precise and effective approach to cancer therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Dentistry II, Peking University School and Hospital of Stomatology & National Center for Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Research Center of…
- State Key Laboratory of Organic-Inorganic Composites, Key Lab of Biomedical Materials of Natural Macromolecules, Beijing Laboratory of Biomedical Materials, College of Materials Science and Engineering, Beijing Universi…
- Henan Provincial Key Laboratory of Surface & Interface Science, School of Material and Chemical Engineering, Zhengzhou University of Light Industry, Zhengzhou, 450002, China.
- Department of Chemistry and Nanoscience, Ewha Womans University, Seoul, 03760, South Korea.
ORCID-Profile: Juyoung Yoon
Förderung
- National Natural Science Foundation of China
- National Key Technologies R&D Program
- Natural Science Foundation of Henan
- Zhongyuan Science and Technology Innovation Leading Talents
- Intergovernmental International Cooperation Project of Beijing Municipal Science and Technology Commission
- China Scholarship Council
- National Research Foundation of Korea
- Bio & Medical Technology Development Program of the National Research Foundation
Zitieren
APA
Peng, Y., Hu, C., Zhang, L., Dong, F., Li, R., Liang, H., Dai, H., Jang, W. J., Cheng, H. B., Zhou, L., Wang, Y., & Yoon, J. (2024). Harnessing Dual Phototherapy and Immune Activation for Cancer Treatment: The Development and Application of BODIPY@F127 Nanoparticles. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202401981
Vancouver
Peng Y, Hu C, Zhang L, Dong F, Li R, Liang H, et al. Harnessing Dual Phototherapy and Immune Activation for Cancer Treatment: The Development and Application of BODIPY@F127 Nanoparticles. Advanced Healthcare Materials. 2024. doi:10.1002/adhm.202401981
BibTeX
@article{Peng2024,
author = {Peng, Yang and Hu, Chenyan and Zhang, Ludan and Dong, Fan and Li, Ruwan and Liang, Huihui and Dai, Hao and Jang, Won Jun and Cheng, Hong-Bo and Zhou, Liming and Wang, Yuguang and Yoon, Juyoung},
title = {Harnessing Dual Phototherapy and Immune Activation for Cancer Treatment: The Development and Application of BODIPY@F127 Nanoparticles},
journal = {Advanced Healthcare Materials},
year = {2024},
doi = {10.1002/adhm.202401981}
}
EUVIMED